Rafferty Asset Management, LLC - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 77 filers reported holding PROQR THRAPEUTICS N V in Q4 2021. The put-call ratio across all filers is 2.49 and the average weighting 0.2%.

Quarter-by-quarter ownership
Rafferty Asset Management, LLC ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q1 2023$46,178
-83.2%
21,680
-92.9%
0.00%
-100.0%
Q1 2022$275,000
-90.0%
303,356
-11.3%
0.00%
-85.7%
Q4 2021$2,740,000
-38.2%
342,083
-35.4%
0.01%
-53.3%
Q3 2021$4,435,000
+12.3%
529,883
-9.5%
0.03%
+20.0%
Q2 2021$3,948,000585,8060.02%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q4 2021
NameSharesValueWeighting ↓
M28 Capital Management LP 1,910,600$2,483,7802.85%
Privium Fund Management B.V. 5,344,446$6,947,7802.07%
DAFNA Capital Management LLC 940,582$1,222,7570.38%
Monaco Asset Management SAM 377,517$490,7720.15%
EcoR1 Capital, LLC 2,980,016$3,874,0210.13%
Ikarian Capital, LLC 472,625$614,4120.07%
FRANKLIN STREET ADVISORS INC /NC 150,000$1950.02%
ADAGE CAPITAL PARTNERS GP, L.L.C. 3,625,467$4,713,1070.01%
GSA CAPITAL PARTNERS LLP 74,084$960.01%
UBS OCONNOR LLC 189,328$246,1260.01%
View complete list of PROQR THRAPEUTICS N V shareholders